Literature DB >> 21931112

Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.

Adriano Boasso1, Caroline M Royle, Spyridon Doumazos, Veronica N Aquino, Mara Biasin, Luca Piacentini, Barbara Tavano, Dietmar Fuchs, Francesco Mazzotta, Sergio Lo Caputo, Gene M Shearer, Mario Clerici, David R Graham.   

Abstract

A delicate balance between immunostimulatory and immunosuppressive signals mediated by dendritic cells (DCs) and other antigen-presenting cells (APCs) regulates the strength and efficacy of antiviral T-cell responses. HIV is a potent activator of plasmacytoid DCs (pDCs), and chronic pDC activation by HIV promotes the pathogenesis of AIDS. Cholesterol is pivotal in maintaining HIV envelope integrity and allowing HIV-cell interaction. By depleting envelope-associated cholesterol to different degrees, we generated virions with reduced ability to activate pDCs. We found that APC activation was dissociated from the induction of type I IFN-α/β and indoleamine-2,3-dioxygenase (IDO)-mediated immunosuppression in vitro. Extensive cholesterol withdrawal, resulting in partial protein and RNA loss from the virions, rendered HIV a more powerful recall immunogen for stimulating memory CD8 T-cell responses in HIV-exposed, uninfected individuals. These enhanced responses were dependent on the inability of cholesterol-depleted HIV to induce IFN-α/β.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931112      PMCID: PMC3217402          DOI: 10.1182/blood-2011-03-344218

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  IDO and tolerance to tumors.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

2.  Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.

Authors:  A M Dyrhol-Riise; P Voltersvik; J Olofsson; B Asjö
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

3.  Boosting p53 with interferon and viruses.

Authors:  Jan Vilcek
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

4.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

5.  Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.

Authors:  David R M Graham; Elena Chertova; Joanne M Hilburn; Larry O Arthur; James E K Hildreth
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules.

Authors:  D C Kalter; H E Gendelman; M S Meltzer
Journal:  Immunol Lett       Date:  1991-10       Impact factor: 3.685

8.  Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells.

Authors:  Zhaohao Liao; David R Graham; James E K Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2003-08       Impact factor: 2.205

9.  Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.

Authors:  Mathias Heikenwalder; Magdalini Polymenidou; Tobias Junt; Christina Sigurdson; Hermann Wagner; Shizuo Akira; Rolf Zinkernagel; Adriano Aguzzi
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

10.  CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

Authors:  Ana E Sousa; Jorge Carneiro; Martin Meier-Schellersheim; Zvi Grossman; Rui M M Victorino
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

View more
  27 in total

1.  HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.

Authors:  Caroline M Royle; David R Graham; Simone Sharma; Dietmar Fuchs; Adriano Boasso
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

2.  Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.

Authors:  B Dominguez-Molina; K Machmach; C Perales; L Tarancon-Diez; I Gallego; J L Sheldon; M Leal; E Domingo; E Ruiz-Mateos
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

3.  TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity.

Authors:  Pradeep D Uchil; Angelika Hinz; Steven Siegel; Anna Coenen-Stass; Thomas Pertel; Jeremy Luban; Walther Mothes
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 4.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

5.  Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors:  Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-23       Impact factor: 2.205

6.  Enhanced innate antiviral gene expression, IFN-α, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection.

Authors:  David Verhoeven; Michael D George; William Hu; Angeline T Dang; Zeljka Smit-McBride; Elizabeth Reay; Monica Macal; Anne Fenton; Sumathi Sankaran-Walters; Satya Dandekar
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 7.  Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.

Authors:  Jamie L Harden; Nejat K Egilmez
Journal:  Immunol Invest       Date:  2012       Impact factor: 3.657

8.  Two new tryptophan derivatives from the seed kernels of Entada rheedei: effects on cell viability and HIV infectivity.

Authors:  L K Nzowa; R B Teponno; L A Tapondjou; L Verotta; Z Liao; D Graham; M-C Zink; L Barboni
Journal:  Fitoterapia       Date:  2013-03-26       Impact factor: 2.882

9.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

10.  New insights into the role of the aryl hydrocarbon receptor in the function of CD11c⁺ cells during respiratory viral infection.

Authors:  Guang-Bi Jin; Bethany Winans; Kyle C Martin; B Paige Lawrence
Journal:  Eur J Immunol       Date:  2014-03-19       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.